REQUEST A DEMO
Total
USD $0.00
Search more companies

Surmount Laboratories Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Surmount Laboratories Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Surmount Laboratories Limited is based in India. The head office is in Mumbai. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on March 28, 1996. The company’s latest financial report indicates a net sales revenue drop of 4.2% in 2024. A growth of 12.77% was recorded in its total assets. The net profit margin of Surmount Laboratories Limited increased by 1.18% in 2024.

Legal Address
Office No. 305, Building No. 3, Wing C-2, Skyline Wealthspace Premises Chslpremier Road, Millar Compound, Vidyavihar West,
Mumbai; Maharashtra; Postal Code: 400086

Contact Details: Purchase the Surmount Laboratories Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Surmount Laboratories Limited report to view the information.
Financial Auditors:
Purchase the Surmount Laboratories Limited report to view the information.
Incorporation Date:
March 28, 1996
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
33%
Purchase this report to view the information.
33%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Surmount Laboratories Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-4.2%
Total Operating Revenue
-5.95%
Operating Profit
4.48%
EBITDA
5.24%
Net Profit/Loss for the Period
10.27%
Total Assets
12.77%
Total Equity
38.6%
Operating Profit Margin
1.1%
Net Profit Margin
1.18%
Return on Equity (ROE)
-7.15%
Debt / Equity
-38.84%
Quick Ratio
0.11%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?